Apolipoprotein E polymorphism in middle-aged Belgian men: Phenotype distribution and relation to serum lipids and lipoproteins

被引:54
作者
Braeckman, L [1 ]
DeBacquer, D [1 ]
Rosseneu, M [1 ]
DeBacker, G [1 ]
机构
[1] STATE UNIV GHENT,DEPT CLIN CHEM,GHENT,BELGIUM
关键词
apo E polymorphism; lipoproteins; lifestyle; epidemiology;
D O I
10.1016/0021-9150(95)05681-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apo E phenotype was determined in 760 Belgian men, aged 35 to 59 years. Serum lipids and lipoproteins were related to the apo E polymorphism in 734 participants. By comparison with the most frequent apo E3/3 phenotype. the presence of the epsilon 2 allele was associated with a lower serum total and non-HDL cholesterol, and with a lower apo B and a higher HDL cholesterol, independently of age, lifestyle factors and apo E concentration. In contrast, the presence of the epsilon 4 allele was associated with a higher serum total and non-HDL cholesterol, and with a lower HDL cholesterol and a lower apo AI. The apo E phenotype explained 17.4% of the variance in apo E concentration: the proportion of the variance in total cholesterol, HDL cholesterol, apo AI and apo B levels explained by the apo E polymorphism was low but statistically significant. Among the lifestyle factors, waist to hip ratio was the only variable significantly associated with apo E concentration. The data suggest that besides the well-documented increasing effect on non-HDL cholesterol, the epsilon 4 allele could further predispose to coronary heart disease through a decreasing effect on HDL while the epsilon 2 allele could exert a protective influence through both a decreasing effect on non-HDL cholesterol and an increasing effect on HDL cholesterol.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 30 条
[1]  
BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[2]  
BURY J, 1986, CLIN CHEM, V32, P265
[3]   DETERMINANTS OF HDL-CHOLESTEROL AND THE HDL-CHOLESTEROL TOTAL CHOLESTEROL RATIO - RESULTS OF THE LUBECK BLOOD-PRESSURE STUDY [J].
CHAMBLESS, L ;
DORING, A ;
FILIPIAK, B ;
KEIL, U .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (03) :578-585
[4]  
DALLONGEVILLE J, 1992, J LIPID RES, V33, P447
[5]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[6]   LIPOPROTEIN PROFILE OF A GREENLAND INUIT POPULATION - INFLUENCE OF ANTHROPOMETRIC VARIABLES, APO-E AND A4 POLYMORPHISM, AND LIFE-STYLE [J].
DEKNIJFF, P ;
JOHANSEN, LG ;
ROSSENEU, M ;
FRANTS, RR ;
JESPERSEN, J ;
HAVEKES, LM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12) :1371-1379
[7]  
DESPRES JP, 1992, MOL CELL BIOCHEM, V113, P151, DOI 10.1007/BF00231535
[8]   APOLIPOPROTEIN-E POLYMORPHISM MODIFIES RELATION OF HYPERINSULINEMIA TO HYPERTRIGLYCERIDEMIA [J].
DESPRES, JP ;
VERDON, MF ;
MOORJANI, S ;
POULIOT, MC ;
NADEAU, A ;
BOUCHARD, C ;
TREMBLAY, A ;
LUPIEN, PJ .
DIABETES, 1993, 42 (10) :1474-1481
[9]  
EGGERTSEN G, 1993, CLIN CHEM, V39, P2125
[10]  
GUDNASON V, 1993, NUTR METAB CARDIOVAS, V3, P136